Pnc Financial Services Group, Inc. Avadel Pharmaceuticals PLC Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$12.55 - $17.22 $2,095 - $2,875	167 New	167 $2,000
Q2 2021 Aug 06, 2021	BUY	$6.73 - $9.05 $3,365 - $4,525	500 New	500 $3,000
Q3 2020 Nov 06, 2020	SELL	$5.02 - $8.98 $1,505 - $2,694	-300 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.25 - $11.75 $2,175 - $3,525	300 New	300 $2,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.